Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / APLS - BioCryst's BCX9930: Alexion's Biggest Headache Now

APLS - BioCryst's BCX9930: Alexion's Biggest Headache Now

Apellis Pharmaceuticals Inc.
  • On September 30, BioCryst reported the results of BCX9930's Proof of Concept as an oral treatment for PNH as Monotherapy.
  • The results have been very promising confirming the good expectations that existed.
  • We can say without any doubt that BCX9930 has a good chance of becoming the first oral drug to treat PNH as monotherapy in the future.
  • My strategy is to keep buying small amounts of stocks for the duration of the current downtrend.

For further details see:

BioCryst's BCX9930: Alexion's Biggest Headache Now
Stock Information
Company Name: Apellis Pharmaceuticals Inc.
Stock Symbol: APLS
Market: NASDAQ
Website: apellis.com
Menu
APLS APLS Quote APLS Short APLS News APLS Articles APLS Message Board
Get APLS Alerts

News, Short Squeeze, Breakout and More Instantly...